Skip to content
Disclosery

13F-HR filed by Finepoint Capital LP

Finepoint Capital LP filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-11, with 37 holding rows worth $289,062,399.

Accession
0000904454-23-000482
Filer
CIK 1608126
Filed
2023-08-11
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2023

A holdings report, 37 entries on the cover page, a total value of $289,062,399 stated on the cover page (in dollars after the unit check, H1), rows summing to $289,062,399 with VALUE read as dollars as filed, 13F file number 028-16580. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
APELLIS PHARMACEUTICALS INC03753U106COM241,690$22,017,959dollars as filed
PROTHENA CORP PLC SHSG72800108Stock317,300$21,665,244dollars as filed
ACADIA PHARMACEUTICALS INC004225108COM846,953$20,284,524dollars as filed
SAGE THERAPEUTICS INC78667J108COM357,765$16,822,110dollars as filed
AMICUS THERAPEUTICS INC03152W109COM1,325,775$16,651,734dollars as filed
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR406,859$16,542,887dollars as filed
MORPHIC HLDG INC61775R105COM287,556$16,485,585dollars as filed
SPRINGWORKS THERAPEUTICS INC85205L107COM608,628$15,958,226dollars as filed
CEREVEL THERAPEUTICS HLDNG I15678U128COM492,545$15,658,006dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock302,000$15,402,000dollars as filed
CRINETICS PHARMACEUTICALS INC COM22663K107Stock797,527$14,371,437dollars as filed
SAREPTA THERAPEUTICS INC803607100COM125,457$14,367,336dollars as filed
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR139,772$12,474,651dollars as filed
CYTOKINETICS INC23282W605COM NEW369,093$12,039,814dollars as filed
CLARIVATE PLCG21810109ORD SHS1,247,406$11,887,779dollars as filed
TRAVERE THERAPEUTICS INC89422G107COM761,721$11,700,035dollars as filed
ARVINAS INC04335A105COM411,500$10,213,430dollars as filed
BAUSCH HEALTH COS INC COM071734107Stock1,165,000$9,320,000dollars as filed
RELAY THERAPEUTICS INC COM75943R102Stock701,570$8,811,719dollars as filed
SOLID BIOSCIENCES INC83422E204COMMON STOCK961,251$5,036,955dollars as filed
ARES ACQUISITION CORPORATIONG33032122*W EXP 02/02/202504,706$403,765dollars as filed
BRIDGETOWN HOLDINGS LTDG1355U121*W EXP 09/30/202895,000$221,960dollars as filed
CHURCHILL CAPITAL CORP V17144T115*W EXP 10/29/202612,000$110,221dollars as filed
CHURCHILL CAPITAL CORP VI17143W119*W EXP 02/17/202540,000$97,200dollars as filed
CALIDI BIOTHERAPEUTICS INC320703119*W EXP 03/14/202655,200$85,176dollars as filed
CHURCHILL CAPITAL CORP VII17144M110*W EXP 02/29/202548,000$76,720dollars as filed
ROSS ACQUISITION II CORPg7641c114WT439,666$74,435dollars as filed
COMPASS DIGITAL ACQUISITION COg2476c123WT459,906$68,434dollars as filed
SWIFTMERGE ACQUISITION CORPG63836111*W EXP 12/13/202490,000$48,020dollars as filed
MARBLEGATE ACQUISITION CORP56608A113*W EXP 08/31/202735,000$41,307dollars as filed
AFTERNEXT HEALTHTECH ACQUISIG01109126*W EXP 99/99/999366,666$31,753dollars as filed
CONYERS PARK III ACQSITN COR21289P110*W EXP 08/12/202571,666$28,583dollars as filed
SUMMIT HEALTHCARE ACQUISITIONg9845f117WT489,999$23,030dollars as filed
CONCORD ACQUISITION II CORP20607u116WT408,333$16,333dollars as filed
HOME PLATE ACQUISITION CORP43734R111*W EXP 09/30/202690,000$14,697dollars as filed
BILANDER ACQUISITION CORP09001T114*W EXP 05/19/202183,749$9,334dollars as filed
CORSAIR PARTNERING CORPG2540H116*W EXP 07/06/202334,666$0dollars as filedValue filed as zero, left out of ratios.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000904454-23-000482this filing2023-08-11acceptance time not in the bulk data set